Drug Type CAR-T |
Synonyms- |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD20 modulators(B-lymphocyte antigen CD20 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B lymphoblastic leukemia lymphoma | Phase 2 | CN | 14 Jan 2024 | |
B lymphoblastic leukemia lymphoma | Phase 2 | CN | 14 Jan 2024 |